Abstract
Radiotherapy is the standard treatment for glioblastoma. Here, we assessed the radiosensitivity of 12 human malignant glioma cell lines in vitro and correlated these data with irradiation-induced cell cycle changes, chemosensitivity profiles and BCL-2 family protein expression. Irradiation at 3 Gy failed to cause major cell cycle perturbations. Radioresistance was associated with collateral sensitivity to the topoisomerase II inhibitors, teniposide and doxorubicin. High levels of BCL-XL and low levels of BAX were independently linked to radioresistance. Ectopic expression of a BAX transgene induced radiosensitization in the LN-18 cell line. Thus, BCL-2 family protein expression modulates radiosensitivity in human glioma cells and targeted alterations in BCL-2 family protein expression are a promising strategy to improve the therapeutic efficacy of radiotherapy for gliomas.
Similar content being viewed by others
References
Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
Bartussek C, Naumann U, Weller M: Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status. Exp Cell Res 253: 432-439, 1999
Zhivotovsky B, Joseph B, Orrenius S: Tumor radiosensitivity and apoptosis. Exp Cell Res 248: 10-17, 1990
Weller M, Malipiero U, Aguzzi A, Reed JC, Fontana A: Protooncogene BCL-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 95: 2633-2643, 1995
Weller M, Rieger J, Grimmel C, Van Meir EG, DeTribolet N, Krajewski S, Reed JC, Von Deimling A, Dichgans J: Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer 79: 640-644, 1998
Naumann U, Weller M: Retroviral BAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy. Int J Cancer 77: 645-648, 1998
Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M: APO2 ligand: A novel lethal weapon against malignant glioma? FEBS Lett 427: 124-128, 1998
Rosen EM, Fan S, Rockwell S, Goldberg ID: The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic irradiation. Cancer Invest 17: 56-72, 1999
Streffer JR, Schuster M, Pohl U, Belka C, Dichgans J, Bamberg M, Weller M: Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions. Anticancer Res 19: 5265-5269, 1999
Wick W, Furnari FB, Naumann U, Cavenee WK, Weller M: PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis. Oncogene 18: 3936-3943, 1999
Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R: BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J Neurol Sci 155: 68-75, 1998
Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC: Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or BCL-2 genes. Brain Pathol 8: 655-667, 1998
Strik H, Deininger M, Streffer J, Grote E, Wickboldt J, Dichgans J, Weller M, Meyermann R: BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry 67: 763-768, 1999
Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, Tsujimoto H, Imanishi T, Ohgaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K, Takahashi T: Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiationinduced apoptosis. Int J Cancer 67: 101-105, 1996
Vogelbaum MA, Tong JX, Perugu R, Gutmann DH, Rich KM: Overexpression of bax in human glioma cell lines. J Neurosurg 91: 483-489, 1999
Shu HK, Kim MM, Chen P, Furman F, Julin CM, Israel MA: The intrinsic radioresistance of glioblastomaderived cell lines is associated with a failure of p53 to induce p21 (BAX) expression. Proc Natl Acad Sci USA 95: 14453-14458, 1998
Shinoura N, Yoshida Y, Asai A, Kirino T, Hamada H: Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax. Oncogene 18: 5703-5713, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Streffer, J.R., Rimner, A., Rieger, J. et al. BCL-2 Family Proteins Modulate Radiosensitivity in Human Malignant Glioma Cells. J Neurooncol 56, 43–49 (2002). https://doi.org/10.1023/A:1014448721327
Issue Date:
DOI: https://doi.org/10.1023/A:1014448721327